Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Current Taxes (2016 - 2023)

Historic Current Taxes for Harvard Bioscience (HBIO) over the last 15 years, with Q2 2023 value amounting to $398000.0.

  • Harvard Bioscience's Current Taxes rose 66538.46% to $398000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $398000.0, marking a year-over-year increase of 66538.46%. This contributed to the annual value of $224000.0 for FY2021, which is 2167.83% down from last year.
  • Harvard Bioscience's Current Taxes amounted to $398000.0 in Q2 2023, which was up 66538.46% from $700000.0 recorded in Q1 2023.
  • Harvard Bioscience's Current Taxes' 5-year high stood at $1.3 million during Q1 2019, with a 5-year trough of $52000.0 in Q2 2022.
  • Over the past 5 years, Harvard Bioscience's median Current Taxes value was $471000.0 (recorded in 2021), while the average stood at $505250.0.
  • In the last 5 years, Harvard Bioscience's Current Taxes soared by 312105.26% in 2019 and then plummeted by 9044.12% in 2022.
  • Over the past 5 years, Harvard Bioscience's Current Taxes (Quarter) stood at $609000.0 in 2019, then crashed by 53.04% to $286000.0 in 2020, then fell by 21.68% to $224000.0 in 2021, then crashed by 76.79% to $52000.0 in 2022, then skyrocketed by 665.38% to $398000.0 in 2023.
  • Its last three reported values are $398000.0 in Q2 2023, $700000.0 for Q1 2023, and $52000.0 during Q2 2022.